EMAIL THIS PAGE TO A FRIEND

Biomaterials

Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma.


PMID 26264646

Abstract

Lipid-calcium-phosphate nanoparticle (NP) delivery of Trp2 peptide vaccine is one of the most effective vaccine strategies against melanoma. However, due to the immunosuppressive microenvironment in the tumor, the achievement of potent immune responses remains a major challenge. NP delivery systems provide an opportunity to deliver chemotherapy agent to modulate the tumor microenvironment (TME) and improve the vaccine activity. Anti-inflammatory triterpenoid methyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate (CDDO-Me) is a broad spectrum inhibitor of several signaling pathways that are important in both cancer cells and cells in the TME. Intravenous delivery of CDDO-Me using poly-lactic-glycolic-acid NP combination with subcutaneous Trp2 vaccine resulted in an increase of antitumor efficacy and apoptotic tumor tissue than Trp2 vaccine alone in B16F10 melanoma. There was a significant decrease of both Treg cells and MDSCs and a concomitant increase in the cytotoxic T-lymphocyte infiltration in TEM of the vaccinated animals. Also, CDDO-Me remodeled the tumor associated fibroblasts, collagen and vessel in TME, meanwhile, enhanced the Fas signaling pathway which could sensitize the tumor cells for cytotoxic T lymphocyte mediated killing. The combination of systemic induction of antigen-specific immune response using Trp2 nanovaccine and targeted modification of the TME with the NP delivered CDDO-Me offers a powerful combination therapy for melanoma.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D9628
3,4-Dihydroxy-L-phenylalanine, ≥98% (TLC)
C9H11NO4
B4429
BIS-TRIS, BioPerformance Certified, cell culture tested, suitable for insect cell culture, ≥98.0%
C8H19NO5
B9754
BIS-TRIS, ≥98.0% (titration)
C8H19NO5
RES1161B-A7
BIS-TRIS, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production., suitable for cell culture
C8H19NO5
PHG0004
BIS-TRIS, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, suitable for cell culture
C8H19NO5
B7535
BIS-TRIS, BioXtra, ≥98.0% (titration)
C8H19NO5
14879
BIS-TRIS, BioUltra, ≥99.0% (NT)
C8H19NO5
C75209
Cholesterol, 94%
C27H46O
C8667
Cholesterol, Sigma Grade, ≥99%
C27H46O
C8503
Cholesterol, from sheep wool, ≥92.5% (GC), powder
C27H46O
C3045
Cholesterol, powder, BioReagent, suitable for cell culture, ≥99%
C27H46O
C3292
Cholesterol, ≥95% (GC), powder, Ash, free
C27H46O
H6167
Cholesterol, from sheep wool, Controlled origin, meets USP/NF testing specifications
C27H46O
C1231
Cholesterol, Plant-Derived, SyntheChol®, PharmaGrade, USP/NF, Ph Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production
C27H46O
S5442
SyntheChol® NS0 Supplement, 500 ×, synthetic cholesterol, animal component-free, aqueous solution, sterile-filtered, suitable for cell culture
C27H46O